Allergan fell $2.09 or 1.2 percent, to $166.12. Baxter International Inc. fell$. 47 or. 6 percent, to $72.07. Boston Scientific Corp. fell$. 08 or. 6 percent, to $12.33.» Read More
Allergan rose $1.18 or. 7 percent, to $167.30. Baxter International Inc. rose$. 84 or 1.1 percent, to $75.11. Boston Scientific Corp. rose$. 15 or 1.2 percent, to $12.53.
Allergan fell$. 48 or. 3 percent, to $165.65. Baxter International Inc. rose$. 44 or. 6 percent, to $74.71. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.44.
SHANGHAI, Sept 4- A Chinese anti-monopoly team visited medical devices and semi-conductor firms in Shanghai at the start of September, the country's Ministry of Commerce said in a statement on Thursday, without making clear the purpose of the visit.
Among all growth funds, health-care investments have increased 14 percent over the last three years, to make up 16 percent of portfolios.
Sept 2- General Electric Co's healthcare unit last week won U.S. Food and Drug Administration approval for its mammography device that produces three-dimensional images to detect breast cancer. Hologic Inc came up with one of the first 3- D breast imaging devices in 2001, which continues to dominate the market.
BARCELONA, Sept 1- A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.
BARCELONA, Aug 31- Swiss engineers, famous for making the world's finest watches, are turning their hands to cardiology with a prototype battery-less pacemaker based on a self-winding wristwatch.
Aug 28- Johnson& Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter. Earlier this year, J&J sold another of its units, Ortho-Clinical Diagnostics Inc to private-equity firm Carlyle Group for $4.15 billion.
SAN FRANCISCO, Aug 28- For a growing U.S. aging population, tracking heart health via a smartphone can mean the difference between life and death.
Aug 28- Johnson& Johnson is recalling some lots of its implant used to correct defects of the jaw following more than a dozen cases of injury. The device, which is used to lengthen and stabilize the lower jawbone and the side of the lower jaw, is being recalled by JNJ unit DePuy Synthes as it may reverse after surgery.
Aug 19- Medtronic Inc Chief Executive Omar Ishrak defended his company's plan to acquire Dublin- based Covidien Plc in a so-called inversion deal, saying the medical device maker will be able to create more U.S. jobs while still paying substantial taxes once the transaction closes.
Diversified U.S. manufacturer 3 M Co and medical equipment makers CareFusion Corp and C.R. Bard Inc are among the companies exploring a potential deal for ConvaTec, the people said. CareFusion, with a market capitalization of $9 billion, and C.R. Bard, with $11.2 billion, would both be able to achieve an inversion if they use their own stock to pay for ConvaTec.
WASHINGTON, Aug 14- A senior U.S. senator said on Thursday he has written to Hospira Inc and urged the drug and medical device maker not to move its tax domicile abroad to save on U.S. taxes.
The death toll from the Ebola virus in West Africa keeps growing to record levels. And ironically, that may be why there's no vaccine, said an expert.
Aug 4- Medical device maker Symmetry Medical Inc said it would sell its orthopedic device components business to privately held Tecomet Inc for $450 million. Symmetry Medical will transfer ownership of its remaining surgical instruments business to its shareholders as a new company.
July 30- Hospira Inc, a pharmaceutical and medical device maker, posted a better-than-expected quarterly profit on higher sales of specialty injectable drugs, and raised its full-year outlook.
July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.
In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion. The move will allow Medtronic to re-domicile to Ireland to take advantage of low corporate tax rates and to access cash overseas without having to pay high repatriation costs.
July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. Covidien said it was indemnifying the manufacturer on certain claims.
July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. The company's two units supplied pelvic mesh products to one of the manufacturers named in the lawsuit and is indemnifying that manufacturer on certain claims.